Laura E. Niklason, President, CEO and Director at Humacyte, Inc. (HUMA), bought 2,050 shares at $7.37 ($15K) on 2024-06-03, disclosed to the SEC on 2024-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| HUMA | SELL | 2024-11-20 | $13.2M | — | Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |